Medicine and Dentistry
Prostate Cancer
100%
Positron Emission Tomography
38%
Prostatectomy
31%
Positron Emission Tomography-Computed Tomography
27%
Choline
24%
Lymph Node Metastasis
22%
Radiation Therapy
22%
Choline C 11
20%
Neoplasm
19%
External Beam Radiotherapy
19%
Positron Emission Tomography
18%
Carbon 11
17%
Recurrent Disease
16%
Biopsy
16%
Malignant Neoplasm
16%
Prostate Specific Membrane Antigen
16%
Peyronie's Disease
15%
Metastatic Carcinoma
13%
Diagnosis
12%
Bladder
11%
Clear Cell Renal Cell Carcinoma
11%
Prostate Specific Antigen
11%
Gastrin Releasing Peptide Receptor
10%
Androgen Deprivation Therapy
10%
Magnetic Resonance Imaging
10%
Testis Cancer
10%
Combination Therapy
10%
Kidney Slice
10%
Biochemical Recurrence
10%
Disease
10%
Kidney Fibrosis
10%
Percutaneous Nephrolithotomy
10%
Computer Assisted Tomography
9%
Nephrectomy
9%
Randomized Controlled Trial
9%
Urology
9%
Bone Metastasis
8%
Radiopharmaceutical Agent
8%
Kidney Metastasis
8%
Epithelial Cell Adhesion Molecule
8%
Sunitinib
8%
Arm
8%
Vasculotropin
8%
Radioactive Tracer
7%
Lymph Node
7%
Volume CT
7%
Ex Vivo
7%
Surgery
6%
Bladder Cancer
6%
Disease Specific Survival
6%
Pharmacology, Toxicology and Pharmaceutical Science
Prostate Cancer
56%
Choline
21%
Bombesin
16%
Neoplasm
15%
Enzalutamide
15%
Malignant Neoplasm
15%
Choline C 11
14%
Gastrin Releasing Peptide Receptor
14%
Chemotherapy
14%
Castration Resistant Prostate Cancer
13%
Carbon 11
12%
Recurrent Disease
12%
Prostate Specific Antigen
10%
Kidney Fibrosis
10%
Peyronie's Disease
10%
Bladder Cancer
9%
Tracer
8%
Disease
8%
Combination Therapy
8%
Docetaxel
8%
Overall Survival
8%
Biochemical Recurrence
7%
Technetium 99m
7%
Fibrosis
7%
Androgen
7%
Radiopharmaceutical Agent
6%
Disease Specific Survival
6%
Progression Free Survival
6%
Sunitinib
5%
Kidney Metastasis
5%
Painful Erection
5%
Urolithiasis
5%
Testis Cancer
5%
Pathophysiology
5%
Muscle Invasive Bladder Cancer
5%
Nephrolithiasis
5%
Homodimer
5%
Renal Cell Carcinoma
5%
Bevacizumab
5%
Zirconium 89
5%
Abiraterone
5%
Plerixafor
5%
Tricine
5%
Keyphrases
Testicular Cancer
9%
Lymph Node Metastasis
7%
Renal Fibrosis
7%
SURTIME
7%
Prostate Cancer
7%
Prostate-specific Antigen
7%
Radical Prostatectomy
7%
Androgen Deprivation Therapy
6%
Positron Emission Tomography
6%
11C-choline PET
6%
Recurrent Prostate Cancer
6%
Positron Emission Tomography-computed Tomography (PET-CT)
5%
Bone Metastasis
5%
Cytoreductive Nephrectomy
5%
Urology
5%
Tumor
5%
Chemotherapy
5%
Patients with Prostate Cancer
5%
Testicular Cancer Survivors
5%
Residual Stones
5%
Peyronie's Disease
5%
Urologic Oncology
5%
Prostate Carcinoma
5%
Precision-cut Kidney Slices
5%
Sunitinib
5%
